Literature DB >> 22790444

FRK controls migration and invasion of human glioma cells by regulating JNK/c-Jun signaling.

Xiuping Zhou1, Lei Hua, Weijian Zhang, Ming Zhu, Qiong Shi, Feng Li, Liexiang Zhang, Chao Song, Rutong Yu.   

Abstract

The Fyn related kinase (FRK), a member of intracellular Src-related tyrosine kinases, was recently reported to function as a potent tumor suppressor in several cancer types. However, the expression level and functional significance of FRK in human malignant glioma, which is characterized by high migration and invasion potential, have never been investigated. We reported here that FRK reduced cell migration and invasion via inhibiting the c-Jun N-terminal protein kinase (JNK)/c-Jun signaling pathway in glioma cells. The mRNA and protein levels of FRK were significantly down-regulated in human primary glioma tissues. In addition, over-expression of FRK inhibited migration and invasion of glioma cells and excretion of the matrix metalloprotease 2 (MMP2), an index of migration and invasion. Furthermore, over-expression of FRK inhibited phosphorylation of JNK and c-Jun, which play important role in cell migration and invasion. Finally, the effects of FRK on cell migration and invasion and JNK/c-Jun inhibition were abolished by anisomycin, a JNK specific activator. In summary, these results clearly indicate that FRK may play a protective role against the progression of glioma by suppressing cell migration and invasion, suggesting that FRK needs to be further studied in its detail mechanism and clinical significant.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22790444     DOI: 10.1007/s11060-012-0933-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  42 in total

1.  Matrigel coated polydimethylsiloxane based microfluidic devices for studying metastatic and non-metastatic cancer cell invasion and migration.

Authors:  K C Chaw; M Manimaran; F E H Tay; S Swaminathan
Journal:  Biomed Microdevices       Date:  2007-08       Impact factor: 2.838

2.  Glial cell-derived neurotrophic factor (GDNF) promotes low-grade Hs683 glioma cell migration through JNK, ERK-1/2 and p38 MAPK signaling pathways.

Authors:  Hyun Song; Aree Moon
Journal:  Neurosci Res       Date:  2006-06-30       Impact factor: 3.304

Review 3.  Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development.

Authors:  Y T Ip; R J Davis
Journal:  Curr Opin Cell Biol       Date:  1998-04       Impact factor: 8.382

4.  Mutation of C-terminal tyrosine residues Y497/Y504 of the Src-family member Bsk/Iyk decreases NIH3T3 cell proliferation.

Authors:  C Oberg-Welsh; C Annerén; M Welsh
Journal:  Growth Factors       Date:  1998       Impact factor: 2.511

Review 5.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

6.  Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms.

Authors:  J Jäälinojä; R Herva; M Korpela; M Höyhtyä; T Turpeenniemi-Hujanen
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

7.  Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells.

Authors:  Zi Li; Xiuling Xu; Lang Bai; Wenshu Chen; Yong Lin
Journal:  J Biol Chem       Date:  2011-04-27       Impact factor: 5.157

Review 8.  Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases.

Authors:  Michael S Serfas; Angela L Tyner
Journal:  Oncol Res       Date:  2003       Impact factor: 5.574

9.  Rak functions as a tumor suppressor by regulating PTEN protein stability and function.

Authors:  Eun-Kyoung Yim; Guang Peng; Hui Dai; Ruozhen Hu; Kaiyi Li; Yiling Lu; Gordon B Mills; Funda Meric-Bernstam; Bryan T Hennessy; Rolf J Craven; Shiaw-Yih Lin
Journal:  Cancer Cell       Date:  2009-04-07       Impact factor: 31.743

10.  Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.

Authors:  P A Forsyth; H Wong; T D Laing; N B Rewcastle; D G Morris; H Muzik; K J Leco; R N Johnston; P M Brasher; G Sutherland; D R Edwards
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more
  24 in total

1.  ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.

Authors:  Susobhan Sarkar; Franz J Zemp; Donna Senger; Stephen M Robbins; V Wee Yong
Journal:  Neuro Oncol       Date:  2015-02-01       Impact factor: 12.300

2.  Geranylgeranyltransferase I promotes human glioma cell growth through Rac1 membrane association and activation.

Authors:  Xiuping Zhou; Jinming Qian; Lei Hua; Qiong Shi; Zhi Liu; Yinfu Xu; Ben Sang; Jianbing Mo; Rutong Yu
Journal:  J Mol Neurosci       Date:  2012-10-17       Impact factor: 3.444

3.  Antagomir-1290 suppresses CD133⁺ cells in non-small cell lung cancer by targeting fyn-related Src family tyrosine kinase.

Authors:  Bo Sun; Nan Yang; Yao Jiang; Huifeng Zhang; Chunying Hou; Chao Ji; Yanyong Liu; Pingping Zuo
Journal:  Tumour Biol       Date:  2015-03-18

4.  Bex2 controls proliferation of human glioblastoma cells through NF-κB signaling pathway.

Authors:  Qingming Meng; Tongle Zhi; Yuewen Chao; Er Nie; Xuebin Xu; Qiong Shi; Lei Hua; Lei Wang; Wenjian Zhan; Yong Wang; Xiuping Zhou; Rutong Yu
Journal:  J Mol Neurosci       Date:  2014-01-04       Impact factor: 3.444

5.  FRK suppresses the proliferation of human glioma cells by inhibiting cyclin D1 nuclear accumulation.

Authors:  Lei Hua; Ming Zhu; Xu Song; Jun Wang; Zhen Fang; Chunting Zhang; Qiong Shi; Wenjian Zhan; Lei Wang; Qingming Meng; Xiuping Zhou; Rutong Yu
Journal:  J Neurooncol       Date:  2014-05-03       Impact factor: 4.130

6.  Plumbagin induces growth inhibition of human glioma cells by downregulating the expression and activity of FOXM1.

Authors:  Xuejiao Liu; Wei Cai; Mingshan Niu; Yulong Chong; Huize Liu; Wenqiang Hu; Dacheng Wang; Shangfeng Gao; Qiong Shi; Jinxia Hu; Xiuping Zhou; Rutong Yu
Journal:  J Neurooncol       Date:  2014-12-21       Impact factor: 4.130

7.  Fisetin suppresses ADAM9 expression and inhibits invasion of glioma cancer cells through increased phosphorylation of ERK1/2.

Authors:  Chien-Min Chen; Yi-Hsien Hsieh; Jin-Ming Hwang; Hsun-Jin Jan; Shu-Ching Hsieh; Shin-Huey Lin; Chung-Yu Lai
Journal:  Tumour Biol       Date:  2014-12-20

8.  Bex2 is critical for migration and invasion in malignant glioma cells.

Authors:  Xiuping Zhou; Xuebin Xu; Qingming Meng; Jinxia Hu; Tongle Zhi; Qiong Shi; Rutong Yu
Journal:  J Mol Neurosci       Date:  2012-08-03       Impact factor: 3.444

9.  FRK inhibits migration and invasion of human glioma cells by promoting N-cadherin/β-catenin complex formation.

Authors:  Qiong Shi; Xu Song; Jun Wang; Jia Gu; Weijian Zhang; Jinxia Hu; Xiuping Zhou; Rutong Yu
Journal:  J Mol Neurosci       Date:  2014-06-27       Impact factor: 3.444

10.  Geranylgeranyltransferase I regulates HIF-1α promoting glioblastoma cell migration and invasion.

Authors:  Xiuping Zhou; Zhi Liu; Qiong Shi; Jiantong Jiao; Wenbin Bian; Xu Song; Jianbing Mo; Ben Sang; Yinfu Xu; Jinming Qian; Yuewen Chao; Rutong Yu
Journal:  J Neurooncol       Date:  2013-03-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.